@NasheCeezet_zw What I tell my patients is that if other patients have more questions or concerns that causes me to go over the 15 min scheduled apt I will give them that time. And I will do the same for you too.
Patients want their own personal appt to go on as long as needed but not others.
@operationdanish The amount of times I have gotten consulted overnight for a <1cm scrotal abscess that I was draining as a med student infuriates me
In cisplatin-ineligible patients with muscle-invasive bladder cancer, enfortumab vedotin–pembrolizumab plus surgery led to better event-free survival (74.7%, vs. 39.4%) and overall survival (79.7%, vs. 63.1%) than surgery alone at 2 years. Full phase 3 KEYNOTE-905 trial results and Research Summary: https://t.co/bzVbmJXHMD
@Dr_mac2 Someone tagged my program when I matched because I said medical students actually do in fact see patients in clinics when a PA student said they don’t lol
@ellie_hen@chris_bryant86@FoxNews Prostate cancer screening stops at 75 years old per guidelines . He was diagnosed from likely bone pain which led to the diagnosis.
@NK__47@DrDiGiorgio This also doesn’t account for location either. Take a look at urology. Huge shortage that’s expected to increase. Even if the number increased 100%, who’s going to cover those overnight consults in rural areas? There is a price to pay from being highly specialized
Radical cystectomy vs bladder-sparing therapy for recurrent high-grade non-muscle invasive bladder cancer: Results from the comparison of intravesical therapy and surgery as treatment. The #CISTO study. Presented by John Gore, MD, MS, FACS @UW. #AUA25 written coverage by @chavarriagaj@UofT > https://t.co/kpOoHUT2W5 @AmerUrological
@DrDiGiorgio@UCSF Also adds to incidental diagnoses that actually don’t correlate with the patients actual condition. Example:
Middle aged pt with MSK back pain getting CT and showing a non-obstructing 1mm punctuate stone and so gets referred to urology for txt by PCP. Patient now insists on OR
In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as compared with the standard procedure and was associated with higher morbidity and mortality. Full SWOG S1011 trial results: https://t.co/mYGY3Zd2MX
🔥Hot off the press in @JUrology. Kudos to @UroAlsyouf and @siadaneshmand!
1⃣237 EP-RPLNDs
2⃣Median LOS: 2d
3⃣30d complications: 13%; no postop ileus or SBO
4⃣Great onc outcomes in primary and post-chemo settings; 7 in-field recurrences
🔗Free access link: https://t.co/qmDozVYx6E